Table 4

Evidence summary on meta-analysis of depression scales for acute and non-acute stroke

InstrumentTotal sample size (number of studies)Sensitivity (95% CI)Specificity (95% CI)Positive predictive value (95% CI)*Negative predictive value (95% CI)*Rule-in clinical utility**Rule-out clinical utility**
Acute stroke*
 GDS-15440 (3)0.81 (0.65 to 0.91)0.77 (0.62 to 0.82)0.63 (0.45 to 0.83)0.89 (0.77 to 0.94)FairGood
 MADRS615 (4)0.85 (0.78 to 0.90)0.79 (0.70 to 0.86)0.67 (0.56 to 0.76)0.91 (0.87 to 0.95)FairGood
 HADS-T411 (3)0.67 (0.29 to 0.91)0.88 (0.62 to 0.97)0.73 (0.36 to 0.94)0.84 (0.64 to 0.96)PoorGood
 HDRS†769 (4)0.86 (0.75 to 0.93)0.86 (0.75 to 0.93)0.75 (0.60 to 0.87)0.93 (0.86 to 0.96)GoodGood
 HADS-D1024 (6)0.85 (0.76 to 0.91)0.69 (0.57 to 0.78)0.57 (0.47 to 0.67)0.90 (0.83 to 0.95)PoorFair
 BDI725 (3)0.83 (0.78 to 0.88)0.76 (0.58 to 0.88)0.63 (0.48 to 0.78)0.90 (0.84 to 0.94)FairGood
Post-acute*
 HDRS*673 (4)0.82 (0.69 to 0.90)0.75 (0.62 to 0.84)0.62 (0.50 to 0.73)0.89 (0.80 to 0.94)FairGood
 CES-D134 (3)0.64 (0.48 to 0.78)0.85 (0.52 to 0.97)0.68 (0.33 to 0.93)0.83 (0.67 to 0.90)PoorGood
 HADS-D544 (3)0.87 (0.46 to 0.98)0.73 (0.65 to 0.79)0.61 (0.39 to 0.70)0.92 (0.71 to 0.99)PoorGood
 BDI638 (3)0.90 (0.62 to 0.98)0.55 (0.19 to 0.86)0.50 (0.27 to 0.78)0.92 (0.50 to 0.99)PoorPoor
  • *PPVs and NPVs assumes depression prevalence of 33% based on an estimate from a systematic review on prevalence of any depression in stroke patients.7

  • **See www.clinicalutility.co.uk for more information.

  • †All scales are self report except the HDRS and the MADRS which are clinician administered scales.

  • BDI, Beck Depression Inventory; CES-D, Center of Epidemiological Studies-Depression Scale; GDS, Geriatric Depression Scale; HADS, Hospital Anxiety and Depression Scale; HDRS, Hamilton Depression Rating Scale; MADRS, Montgomery Asberg Depression Rating Scale.